Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Post-operative adjuvant therapy|DRUG: neoadjuvant therapy|PROCEDURE: therapeutic surgical procedure|RADIATION: Radiation therapy with concurrent Paclitaxel|DRUG: Hormonal Therapy
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)